PubMed

Effect of acute hyperglycemia on insulin secretion in humans.

Toschi E, Camastra S, Sironi AM, Masoni A, Gastaldelli A, Mari A, Ferrannini E, Natali A.

Diabetes. 2002 Feb;51 Suppl 1:S130-3.PMID: 11815471 [PubMed - indexed for MEDLINE]Related articlesFree article

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.

Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.

Eur J Clin Invest. 2000 May;30(5):411-8.PMID: 10809901 [PubMed - indexed for MEDLINE]Related articles

Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.

Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.

J Clin Endocrinol Metab. 1990 Jun;70(6):1594-602.PMID: 2189885 [PubMed - indexed for MEDLINE]Related articles

Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.

van Haeften TW, Voetberg GA, Gerich JE, van der Veen EA.

J Clin Endocrinol Metab. 1989 Nov;69(5):1059-64.PMID: 2677037 [PubMed - indexed for MEDLINE]Related articles

Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

Greenbaum CJ, Prigeon RL, D'Alessio DA.

Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

Disturbances in beta-cell function in impaired fasting glycemia.

van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE.

Diabetes. 2002 Feb;51 Suppl 1:S265-70.PMID: 11815491 [PubMed - indexed for MEDLINE]Related articlesFree article

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.

Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA.

Diabetes. 1987 Nov;36(11):1320-8.PMID: 3117609 [PubMed - indexed for MEDLINE]Related articles

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.

J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article

The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.

Matthews DR, Boland O.

Metabolism. 1997 Dec;46(12 Suppl 1):5-9.PMID: 9439551 [PubMed - indexed for MEDLINE]Related articles

Arginine-induced insulin release in glucokinase-deficient subjects.

Pueyo ME, Clement K, Vaxillaire M, Passa P, Froguel P, Robert JJ, Velho G.

Diabetes Care. 1994 Sep;17(9):1015-21.PMID: 7988299 [PubMed - indexed for MEDLINE]Related articles

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

Degn KB, Juhl CB, Sturis J, Jakobsen G, Brock B, Chandramouli V, Rungby J, Landau BR, Schmitz O.

Diabetes. 2004 May;53(5):1187-94.PMID: 15111485 [PubMed - indexed for MEDLINE]Related articlesFree article

Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.

Ligtenberg JJ, Reitsma WD, van Haeften TW.

Horm Metab Res. 2001 Jun;33(6):361-4.PMID: 11456286 [PubMed - indexed for MEDLINE]Related articles

Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC.

Metabolism. 1989 Aug;38(8):767-72.PMID: 2668699 [PubMed - indexed for MEDLINE]Related articles

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.

Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J.

Diabetes Care. 2002 Sep;25(9):1607-11.PMID: 12196435 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.

Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1775-81. Epub 2007 Feb 13.PMID: 17299078 [PubMed - indexed for MEDLINE]Related articlesFree article

Age-related differences in the pancreatic beta-cell response to hyperglycemia after eccentric exercise.

Krishnan RK, Hernandez JM, Williamson DL, O'Gorman DJ, Evans WJ, Kirwan JP.

Am J Physiol. 1998 Sep;275(3 Pt 1):E463-70.PMID: 9725813 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.

Kjems LL, Vølund A, Madsbad S.

Diabetologia. 2001 Oct;44(10):1339-48.PMID: 11692185 [PubMed - indexed for MEDLINE]Related articles